NVS: Novartis AG – Depositary Receipt (Common Stock) Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) 46,750.00
Book Value / Share 21.35
Price / Book n/a
NCAV ($M) -22,714.00
NCAV / Share -10.37
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.20
Return on Assets (ROA) 0.13
Return on Equity (ROE) 0.28

Liquidity (mrq)
Quick Ratio 0.93
Current Ratio 1.16

Balance Sheet (mrq) ($M)
Current Assets 30,481.00
Assets 99,945.00
Liabilities 53,195.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 46,660.00
Operating Income 12,642.00
Net Income 14,850.00

Cash Flow Statement (mra) ($M)
Cash From Operations 14,458.00
Cash from Investing 5,596.00
Cash from Financing -14,278.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-02 13G/A BlackRock Inc. 6.10 6.41

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-12 213,496 2,099,603 10.17
2024-04-11 251,767 1,623,290 15.51
2024-04-10 259,184 2,399,212 10.80
2024-04-09 151,666 1,375,935 11.02
2024-04-08 230,204 1,535,120 15.00

(click for more detail)

Similar Companies
ABBV – AbbVie Inc. ABT – Abbott Laboratories
ADCT – ADC Therapeutics SA ANRO – Alto Neuroscience, Inc.
ANVS – Annovis Bio, Inc.


Financial data and stock pages provided by
Fintel.io